ABH Healthcare Ltd
- Market Cap ₹ 117 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 51.8
- Book Value ₹
- Dividend Yield %
- ROCE 16.9 %
- ROE 39.4 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 37.2%
Cons
- Earnings include an other income of Rs.2.08 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| 3.50 | 28.48 | 37.85 | |
| 3.28 | 25.36 | 32.09 | |
| Operating Profit | 0.22 | 3.12 | 5.76 |
| OPM % | 6.29% | 10.96% | 15.22% |
| 0.00 | 1.10 | 2.08 | |
| Interest | 0.00 | 1.37 | 2.93 |
| Depreciation | 0.00 | 1.59 | 1.79 |
| Profit before tax | 0.22 | 1.26 | 3.12 |
| Tax % | 27.27% | 39.68% | 27.88% |
| 0.16 | 0.76 | 2.25 | |
| EPS in Rs | 16.00 | 3.80 | 11.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 196% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| Last Year: | 39% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Equity Capital | 0.10 | 2.00 | 2.00 |
| Reserves | 0.16 | 2.82 | 4.61 |
| 21.72 | 22.57 | 37.68 | |
| 5.02 | 5.87 | 9.35 | |
| Total Liabilities | 27.00 | 33.26 | 53.64 |
| 23.55 | 22.79 | 34.57 | |
| CWIP | 0.00 | 0.63 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| 3.45 | 9.84 | 19.07 | |
| Total Assets | 27.00 | 33.26 | 53.64 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Net Cash Flow | |||
| Free Cash Flow | |||
| CFO/OP |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Debtor Days | 109.50 | 75.49 | 115.53 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 109.50 | 75.49 | 115.53 |
| Working Capital Days | -566.27 | -7.05 | 28.64 |
| ROCE % | 10.65% | 16.88% |
Documents
Annual reports
No data available.